Knowledge

During Covid, as hospitals faced a shortage of caregivers and struggled to monitor patients in the ICU, we were able to offer a solution. We conceptualized a validation study to deploy our remote breathing rate monitoring solution for quarantined spaces. Here, breathing/ respiratory rate was found to be vital for treatment planning and resource management.

Clinical trials

To evaluate rayIot's breathing rate monitoring among adults in a quarantine setting

The goal of the study was:

To validate the accuracy of rayIot with the industry standard of measurement

Methodology

We were able to collect 250 breathing instances during the pilot. We referenced our device’s breathing rate with manual counting of breaths, which is an industry-standard. Manual counting is an exhaustive task, prone to error in a rushed clinical scenario, raising the need for an automated replacement. In our study, our device continuously monitored breathing rate of the volunteers who would manually count their breaths for 60 seconds at randomized intervals.

Results

We tested our technology with a limited data set of 250 points in a non-clinical study setting and achieved 98% accuracy. We had also achieved a similar result with medically approved devices in a clinical setting with 33,600 data points. In a pre quarantine setting where patients showed mild symptoms, our clinically tested algorithms could monitor their breathing rate and therefore their health status effectively.